Low Expression of TBX4 Predicts Poor Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma

This study was designed to investigate the expression of the T-box transcription factor 4 (TBX4), a tumor biomarker that was previously identified by proteomics, in pancreatic ductal adenocarcinoma (PDAC) and evaluate its clinical utility as a potential prognostic biomarkers for PDAC. The expression...

Descripción completa

Detalles Bibliográficos
Autores principales: Zong, Meijuan, Meng, Meng, Li, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3179144/
https://www.ncbi.nlm.nih.gov/pubmed/21954337
http://dx.doi.org/10.3390/ijms12084953

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3179144/
https://www.ncbi.nlm.nih.gov/pubmed/21954337
http://dx.doi.org/10.3390/ijms12084953

Ejemplares similares